SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-017826
Filing Date
2020-06-29
Accepted
2020-06-29 21:50:57
Documents
1
Period of Report
2020-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4085
  Complete submission text file 0000899243-20-017826.txt   5658
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O PHARMATHENE, INC ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address
GILL JOHN (Reporting) CIK: 0001409939 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 201000158